RxDoctor Payments Data

Brian Daily, MD

Family Medicine · Wilmington, NCNPI 1427492503

Payments from drug & device makers

$1,159in general payments, 2019–2025

Across 78 payments — averaging $14.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$230
  • Pfizer$117
  • Novo Nordisk$106
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$53
  • AbbVie$53
  • Amgen$45
  • plus $555 from 20 others

What the payments were for

  • Food & beverage$1,159100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,159 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$102,067
Medicare patients
246
Services billed
1,986

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban22$22,222
FarxigaDapagliflozin Propanediol16$16,367
RybelsusSemaglutide11$10,233
LinzessLinaclotide14$7,462
TradjentaLinagliptin12$6,134
Janumet XrSitagliptin Phos/Metformin Hcl11$5,999
Atorvastatin Calcium121$1,601
Levothyroxine Sodium76$1,287
Amlodipine Besylate87$797
Lisinopril84$792
Pantoprazole Sodium53$769
Rosuvastatin Calcium67$695
Tamsulosin Hcl60$691
Metoprolol Succinate48$627
Pravastatin Sodium35$618

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$117$22,22222 claims
AstraZenecaFarxiga$230$16,36716 claims
Novo NordiskRybelsus$106$10,23311 claims
AbbVieLinzess$53$7,46214 claims
Boehringer IngelheimTradjenta$39$6,13412 claims
MerckJanumet Xr$36$5,99911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Wilmington

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →